Carousel of Possible Dreams

When:
September 29, 2016 @ 5:00 pm – 8:00 pm
2016-09-29T17:00:00-07:00
2016-09-29T20:00:00-07:00
Where:
Carousel Court at South Coast Plaza
3333 Bristol St
Costa Mesa, CA 92626
USA
Cost:
Free
Contact:
Catherine Raack
949-859-6312

WE DREAM OF A CURE FOR NEUROBLASTOMA

In honor of Pediatric Cancer Awareness month, the Festival of Children Foundation is teaming up with the Pediatric Cancer Research Foundation and Friends of Cathryn to raise funds for New Approaches to Neuroblastoma Therapy. This month long fundraising campaign will culminate to the Carousel of Possible Dreams event on September 29, 2016 at Carousel Court at South Coast Plaza. We invite you to join us as our Ambassadors ride the carousel to celebrate our fundraising success!

Never underestimate the power of what one person can do! Join us this September to raise funds for new therapies and new hope for families with children diagnosed with Neuroblastoma. It’s Easy:

Carousel of Possible Dreams charity event announcement

About Carousel of Possible Dreams:

Carousel of Possible Dreams is an innovative fundraising program from Festival of Children Foundation that helps fund the Dreams of children organizations. In 2009 Orange County community leaders climbed aboard the Carousel at South Coast Plaza Retail Center in Costa Mesa, CA, and weren’t let off until the fundraising goal was reached! In just two hours, these riders raised nearly $80,000 and we were able to grant 100% of the charity’s dreams. Now the Carousel of Possible Dreams a signature fundraising event of Festival of Children, helping to make charities’ dream projects a reality.

About New Approaches to Neuroblastoma Therapy (NANT):

NANT is a global consortium of pediatric oncologists devoted to bringing new therapy and new hope to families of children with Neuroblastoma (www.nant.org). The NANT consortium offers hope and resources to patients and their families with relapsed/refractory neuroblastoma when front-line, standard therapy fails. Established in 2000, NANT is the only consortium in the world solely dedicated to developing novel treatments and biomarkers through early clinical trials (Phase I/II) for children whose disease has become resistant to front-line therapies.


NANT addresses the most difficult but most relevant question for children with high-risk neuroblastoma: “What is the best strategy to attack this disease when it has escaped all standard front-line therapies?” NANT believes that a comprehensive approach that targets the cancer cells but also their surrounding environment by a team of researchers with converging expertise will make a difference. NANT’s vision is to develop and test new therapies that target both neuroblastoma cells and normal cells around the tumor and in the immune system to improve the outcome for children with high-risk neuroblastoma with fewer side effects.